InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
40%
T+90 mean return
-1.1%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Barrett Elizabeth A., Chief Executive Officer. Director active across 1 company, notably UroGen Pharma Ltd.. Cumulatively, 11 reports have been logged. Regulator: SEC (Form 4). The full history is free.
Declarations11 total
5,000 sharesOrdinary SharesSEC:0001437749-23-002358:0
5,000 sharesOrdinary SharesSEC:0001209191-22-006383:0
5,000 sharesOrdinary SharesSEC:0001209191-22-006383
105,689 sharesOrdinary SharesSEC:0001209191-22-002305
105,689 sharesOrdinary SharesSEC:0001209191-22-002305:0
8,807 sharesOrdinary SharesSEC:0001209191-21-046340
8,807 sharesOrdinary SharesSEC:0001209191-21-046344:0
8,807 sharesOrdinary SharesSEC:0001209191-21-046340:0
8,807 sharesOrdinary SharesSEC:0001209191-21-046344
8,807 sharesOrdinary SharesSEC:0001209191-21-034823
8,807 sharesOrdinary SharesSEC:0001209191-21-034823:0
11 of 11 declarations
About Barrett Elizabeth A.
Barrett Elizabeth A. is the Chief Executive Officer of UroGen Pharma Ltd. She leads the company with a strategic vision focused on innovation and the development of treatments for urological diseases. Elizabeth plays a crucial role in defining the company's objectives and overseeing its operations to ensure growth and success.
